Activin and Inhibin

hMAO-B-IN-4 (compound B10) is a selective, reversible and blood–brain barrier (BBB) penetrable human monoamine oxidase-B ( hMAO-B ) inhibitor with an IC 50 value and a K i value of 0.067 and 0.03 μM, respectively. hMAO-B-IN-4 inhibits hMAO-A with an

HOIPIN-8 is a potent inhibitor of linear ubiquitin chain assembly complex (LUBAC) with an IC 50 of 11 nM. HOIPIN-8 is a HOIPIN-1 derivative with enhanced the potency by 255-fold in the petit-LUBAC inhibition, and 10-fold and 4-fold in the LUBAC- and

HOIPIN-8 is a potent inhibitor of linear ubiquitin chain assembly complex (LUBAC) with an IC 50 of 11 nM. HOIPIN-8 is a HOIPIN-1 derivative with enhanced the potency by 255-fold in the petit-LUBAC inhibition, and 10-fold and 4-fold in the LUBAC- and

HOIPIN-8 is a potent inhibitor of linear ubiquitin chain assembly complex (LUBAC) with an IC 50 of 11 nM. HOIPIN-8 is a HOIPIN-1 derivative with enhanced the potency by 255-fold in the petit-LUBAC inhibition, and 10-fold and 4-fold in the LUBAC- and

Homoeriodictyol 7-O-β-D-glucoside is a natural platelet-activating factor (PAF) antagonist. Homoeriodictyol 7-O-β-D-glucoside inhibits human and rabbit platelet aggregation induced by PAF, with an IC 50 of 0.8 μMIn VitroHomoeriodictyol

Homoeriodictyol 7-O-β-D-glucoside is a natural platelet-activating factor (PAF) antagonist. Homoeriodictyol 7-O-β-D-glucoside inhibits human and rabbit platelet aggregation induced by PAF, with an IC 50 of 0.8 μMIn VitroHomoeriodictyol

Homologous recombination-IN-1 is a novel RAD51-BRCA2 protein-protein interaction inhibitor ( EC 50 =19 μM). Homologous recombination-IN-1 can interfere with homologous recombination.In VitroHomologous recombination-IN-1 (10-40 μM: 5 h) reduces cell

Homologous recombination-IN-1 is a novel RAD51-BRCA2 protein-protein interaction inhibitor ( EC 50 =19 μM). Homologous recombination-IN-1 can interfere with homologous recombination.In VitroHomologous recombination-IN-1 (10-40 μM: 5 h) reduces cell

Homologous recombination-IN-1 is a novel RAD51-BRCA2 protein-protein interaction inhibitor ( EC 50 =19 μM). Homologous recombination-IN-1 can interfere with homologous recombination.In VitroHomologous recombination-IN-1 (10-40 μM: 5 h) reduces cell

Homologous recombination-IN-1 is a novel RAD51-BRCA2 protein-protein interaction inhibitor ( EC 50 =19 μM). Homologous recombination-IN-1 can interfere with homologous recombination.In VitroHomologous recombination-IN-1 (10-40 μM: 5 h) reduces cell

Honokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.In VitroHonokiol DCA (20-40 μM: 24-48

Honokiol DCA (Honokiol dichloroacetate) is a dichloroacetate analog of Honokiol. Honokiol DCA can inhibit the growth of human prostate cancer cells in vitro and suppress the androgen receptor (AR) protein level.In VitroHonokiol DCA (20-40 μM: 24-48